Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ⅰ Study of ADG106 Administered in Patients With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma

NCT03802955 is registered in ClinicalTrials.gov with Adagene (Suzhou) Limited as lead sponsor.

NCT NCT03802955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03802955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ⅰ Study of ADG106 Administered in Patients With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma
Lead sponsor
Adagene (Suzhou) Limited
Phase
Phase 1
Overall status
Completed
Start date
December 20, 2018
Completion date
November 1, 2021
Enrollment
62 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

non-hodgkin lymphoma, solid tumor